Лечение болезни Альцгеймера в Швейцарии

Ведущие частные клиники Швейцарии предлагают качественное лечение и поддержку при болезни Альцгеймера. Пациентам предоставлен доступ к инновационным методам терапии и заботливому уходу. Опытные специалисты работают над улучшением качества жизни пациентов и поддержкой их семей.

Alzheimer's disease. Alzheimer's disease is now the most common form of neurodegenerative dementia in the United States with a disproportionate disease burden in minority populations. Deficits in the ability to encode and store new memories characterizes the initial stages of the disease. Subsequent progressive changes in cognition and behavior accompany the later stages. Changes in amyloid precursor protein (APP) cleavage and production of the APP fragment beta-amyloid (Aβ) along with hyperphosphorylated tau protein aggregation coalesce to cause reduction in synaptic strength, synaptic loss, and neurodegeneration. Metabolic, vascular, and inflammatory changes, as well as comorbid pathologies are key components of the disease process. Symptomatic treatment offers a modest, clinically measurable effect in cognition, but disease-modifying therapies are desperately needed. Copyright © 2019 Elsevier B.V. All rights reserved.